Centro Riferimento Oncologico, IRCCS, Istituto Nazionale Tumori

Aviano

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, HER2 Positive Breast Cancer

Studies at this site

• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early